The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DMTomohiro Koga, Atsushi Kawakami, Keita Fujikawa et al.|Lara D. Veeken|2012Cited by 321
IgG4-related disease in the Japanese population: a genome-wide association studyChikashi Terao, Takayoshi Nishino, Masao Ôta et al.|The Lancet Rheumatology|2019Cited by 90
Association of distinct clinical subsets with myositis‐specific autoantibodies towards anti‐155/140‐kDa polypeptides, anti‐140‐kDa polypeptides, and anti‐aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single‐centre, cross‐sectional studyKeita Fujikawa, Katsumi Eguchi, Atsushi Kawakami et al.|Scandinavian Journal of Rheumatology|2009Cited by 88
Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositisYoshiro Horai, Atsushi Kawakami, Tomohiro Koga et al.|Modern Rheumatology|2014Cited by 85
Putative IgG4-related pituitary disease with hypopituitarism and/or diabetes insipidus accompanied with elevated serum levels of IgG4Ai Haraguchi, Katsumi Eguchi, Ai Era et al.|Endocrine Journal|2010Cited by 40